NCT04840914View on ClinicalTrials.gov

A Study of LY3461767 in Participants With Chronic Heart Failure With Reduced Ejection Fraction

PHASE1CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

June 1, 2021

Primary Completion Date

May 9, 2024

Study Completion Date

May 9, 2024

Conditions
Chronic Heart Failure With Reduced Ejection Fraction
Interventions
DRUG

LY3461767

Administered SC.

DRUG

Placebo

Administered SC.

Trial Locations (7)

27599

University of North Carolina, Division of Cardiology, Chapel Hill

48202

Henry Ford Hospital, Detroit

63110

Washington University, St Louis

300-0053

Tsuchiura Kyodo Hospital, Tsuchiura

236-0051

Kanagawa Prefectural Hospital Organization Kanagawa Cardiovascular and Respiratory Center, Kanazawa Ward,Yokohama

564-8565

National Cerebral and Cardiovascular Center, Suita-shi

113-8655

The University of Tokyo Hospital, Bunkyo-ku

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY